GSK Plc (NYSE:GSK) shares traded in the green on Wednesday, snapping six straight days of losses. The stock closed up 0.65% at $38.46.
GSK has gained 9% in the last 12 months and fallen 7% in the last one month. YTD, the stock has trailed compared to the broader S&P 500 market, which rose 15.5%, vs the company’s gain of 3.10%.
Looking at Seeking Alpha’s Quant Ratings, this UK-based company has Hold rating with a score of 3.14 out of 5.
When it comes to Wall Street analysis, 4 out of 8 analysts recommend a Hold, 2 rate it as a Strong Buy, 1 rates it as a Buy, 1 rates it as Sell.
According to Allka Research, “From a global perspective, an additional key factor that will accelerate the growth of GSK’s operating income and revenue is an increase in its R&D spending.”
Seeking Alpha analysts have a Buy rating on the company.